We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 27 APRIL 2022
Blockbuster Blood Thinning Patent Revoked
HGF Law
Mr Justice Meade has revoked Bristol Myers Squibb's European patent No. EP1427415 and corresponding supplementary protection certificate that relate to the compound Apixaban (ELIQUIS) for lack of plausibility.
United KingdomIntellectual Property







